Seattle, WA, United States of America

Lichun Dong

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Lichun Dong: Innovator in Immunology

Introduction

Lichun Dong is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of immunology. With a total of 13 patents, he has made remarkable strides in developing therapeutic compositions aimed at combating viral infections, particularly herpes simplex virus.

Latest Patents

Among his latest patents, Lichun Dong has developed compositions and methods for vaccinating against HSV-2. This invention focuses on therapeutic compositions and methods for systemic immune activation, which are effective in eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. These methods are particularly effective for protecting mammals from herpes simplex virus. Additionally, he has created polynucleotide compositions that serve similar purposes, specifically targeting HSV gD2 polypeptides.

Career Highlights

Lichun Dong has worked with notable organizations such as Vical Incorporated and the University of Washington. His work in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Some of his notable coworkers include Adrian Vilalta and David Martin Koelle, who have collaborated with him on various projects related to immunology and vaccine development.

Conclusion

Lichun Dong's innovative work in the field of immunology, particularly in developing vaccines against HSV-2, showcases his dedication to advancing medical science. His contributions continue to have a lasting impact on the fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…